Monday, February 5, 2018

Emerald Health Therapeutics Appoints Paul R. Dillman, Jr. to Vice President of Sales and Marketing


Source:  Emerald Health Therapeutics, Inc.

Senior marketing executive with three decades global consumer packaged goods experience to lead Emerald’s marketing and sales strategy

Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald”) today announced the appointment of Paul R. Dillman, Jr., as the Company's Vice President of Sales and Marketing. Mr. Dillman will be responsible for marketing, sales, and customer service, and will lead Emerald’s brand strategy and execution as the Company prepares for anticipated legalization of adult use cannabis in Canada by July 2018.

“Paul has been instrumental in preparing for and executing sales growth as a senior leader at some of the world’s most successful fast-moving consumer packaged goods companies. His strategic and tactical marketing expertise will be invaluable as we position Emerald for leadership in the Canadian and global cannabis industry,” said Chris Wagner, Chief Executive Officer of Emerald.

Mr. Dillman brings three decades of experience in global marketing, sales, and general management to Emerald and has held senior leadership positions at The Coca-Cola Company, AB InBev, Philip Morris, and Kraft Foods.

Mr. Dillman earned a Bachelor of Science from West Point (United States Military Academy) and a Master of Science in Systems Management from the University of Southern California.

"I'm thrilled to join the dynamic organization that Emerald is building,” said Mr. Dillman. “With its current expansion projects and product innovation plans, Emerald is poised to be a premiere provider of cannabis for medical and adult-use consumers. I look forward to planning and executing a marketing and sales strategy that will contribute to this goal.”

Mr. Dillman has been granted an option to acquire up to 150,000 common shares vesting over three years.

Join us on our journey of making lives better through cannabis science.
About Emerald Health Therapeutics Inc. 

Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) operates through Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned subsidiary and Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations. Through Botanicals, Emerald is authorized to produce and sell dried medical cannabis flower and medical cannabis oil. It currently operates an indoor facility in Victoria, BC, and is building a 500,000 s.f. greenhouse on 32 acres in Metro Vancouver, with expansion potential to 1 million s.f. to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald also owns 50% of Pure Sunfarms, a partnership with Village Farms that is converting an existing 1.1 million s.f. greenhouse in Delta, BC from growing tomatoes to growing cannabis. Emerald’s team is highly experienced in life sciences, product development and large-scale agribusiness. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical and nutraceutical products designed to provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.
Please visit www.emeraldhealth.ca for more information or contact:

No comments:

Post a Comment